Hepatitis

This internet file (web page) provides lessons on co-infection of HIV and hepatitis C. It discusses treatment; responder relapsers, partial responders, and null responders; experimental treatment; preventing cellular infection; viral enzyme target; immune therapies; and prevention. It includes two video clips, one with a hepatitis C patient, who relates her story, and the other with a doctor explains the importance of knowing about HCV for HIV infected individuals.

This guide details safety, efficacy, and access information on rifapentine. The guide also provides activists with the evidence and content needed to advocate for rifapentine to be available, accessible, and affordable to those who may need it.

This workbook is designed for patient's use throughout treatment with triple therapy--pegylated interferon, ribavirin, and boceprevir. The workbook explains triple therapy, how and when to take medications, what to do if you miss a dose, the length of treatment, if treament does not work, treatment tracks and which you should follow, and dealing with side effects. It provides sample medication schedules, a viral load chart, the notes to bring to the provider, and treatment visit schedule.

An educational video and presentation intended to train health care providers to perform Tuberculin skin testing.

This information sheet discusses the hepatitis B vaccine. It presents statistics on the incidence of hepatitis B in the United States and describes the hepatitis B virus (HBV) and its effect on the liver, the symptoms, the difference between acute (short-term) illness and chronic (long-term) infection, transmission, and prevention.

A fact sheet on the QuantiFERON (also called QFT test), including information on how test results are interpreted. There is also content on the difference between latent TB infection and TB disease.

This information sheet presents facts about viral hepatitis in tabular format. It discusses hepatitis A, B, and C. It lists statistics; routes of transmission; persons at risk; incubation period; symptoms of acute infection; the likelihood of symptomatic acute infection; the potential for chronic infection; the severity; serologic tests for acute and chronic infection; screening recommendations for chronic infection; treatment; vaccination recommendations and schedule, if any; and testing recommendations.

This information sheet discusses the hepatitis B vaccine. It presents statistics on the incidence of hepatitis B in the United States and describes the hepatitis B virus (HBV) and its effect on the liver, the symptoms, the difference between acute (short-term) illness and chronic (long-term) infection, transmission, and prevention.

This is a flipbook from the Multnomah Health Department for patients with tuberculosis (TB) disease. The flipbook has information on TB disease, testing, case management, treatment, and more.

This is a flipbook from the Multnomah Health Department for patients with tuberculosis (TB) disease. The flipbook has information on TB disease, testing, case management, treatment, and more.